首页 > 最新文献

Journal of Bioethical Inquiry最新文献

英文 中文
The Role of Nurses in Advancing Healthcare Equity and Quality of Care : A Scoping Review. 护士在促进医疗公平和护理质量中的作用:范围审查。
IF 1.5 3区 哲学 Q2 ETHICS Pub Date : 2025-12-01 DOI: 10.1007/s11673-025-10506-8
Nour A Alrida

Health equity is a primary principle of healthcare delivery, aiming to ensure that all healthcare recipients have access to quality healthcare equally, regardless of their social, demographic, and economic characteristics. The current paper explores the role of nurses in advancing healthcare equity and quality of care. A scoping review was conducted to investigate the relevant international and national articles in major databases, including CINAHL, MEDLINE, Google Scholar, EBSCO, and SCOPUS, using relevant keywords such as "Health Equity," "Quality of Care," and "Role of Nurses." The review highlighted that, as nurses are the frontline healthcare providers in diverse healthcare settings, their roles extend beyond routine healthcare to incorporate more advanced roles in health education, advocacy, and support services, significantly improving access, quality, and equity in healthcare. Several barriers and issues have limited nurses' impact in reducing disparities, but other strategies could be employed to address them. They include telehealth and school-based health centrer. Nursing professionals are in an exceptional position to be transformative in achieving health equity and delivering good quality and accessible healthcare to all individuals and communities.

卫生公平是卫生保健服务的一项基本原则,旨在确保所有卫生保健接受者不论其社会、人口和经济特征如何,都能平等获得高质量的卫生保健服务。本文探讨了护士在促进医疗公平和护理质量方面的作用。使用“健康公平”、“护理质量”和“护士角色”等相关关键词,对主要数据库(包括CINAHL、MEDLINE、谷歌Scholar、EBSCO和SCOPUS)中的相关国际和国内文章进行了范围综述。该综述强调,由于护士是各种医疗保健机构的一线医疗保健提供者,她们的作用超越了常规医疗保健,在健康教育、宣传和支持服务方面发挥了更高级的作用,显著提高了医疗保健的可及性、质量和公平性。一些障碍和问题限制了护士在减少差距方面的影响,但可以采用其他策略来解决这些问题。它们包括远程保健和校本保健中心。护理专业人员在实现卫生公平和向所有个人和社区提供高质量和可获得的卫生保健方面处于特殊地位,具有变革性。
{"title":"The Role of Nurses in Advancing Healthcare Equity and Quality of Care : A Scoping Review.","authors":"Nour A Alrida","doi":"10.1007/s11673-025-10506-8","DOIUrl":"https://doi.org/10.1007/s11673-025-10506-8","url":null,"abstract":"<p><p>Health equity is a primary principle of healthcare delivery, aiming to ensure that all healthcare recipients have access to quality healthcare equally, regardless of their social, demographic, and economic characteristics. The current paper explores the role of nurses in advancing healthcare equity and quality of care. A scoping review was conducted to investigate the relevant international and national articles in major databases, including CINAHL, MEDLINE, Google Scholar, EBSCO, and SCOPUS, using relevant keywords such as \"Health Equity,\" \"Quality of Care,\" and \"Role of Nurses.\" The review highlighted that, as nurses are the frontline healthcare providers in diverse healthcare settings, their roles extend beyond routine healthcare to incorporate more advanced roles in health education, advocacy, and support services, significantly improving access, quality, and equity in healthcare. Several barriers and issues have limited nurses' impact in reducing disparities, but other strategies could be employed to address them. They include telehealth and school-based health centrer. Nursing professionals are in an exceptional position to be transformative in achieving health equity and delivering good quality and accessible healthcare to all individuals and communities.</p>","PeriodicalId":50252,"journal":{"name":"Journal of Bioethical Inquiry","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145649623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting Illicit Tobacco Trade in Australia: Recent Amendments to State and Territory Tobacco Control Laws. 打击非法烟草贸易在澳大利亚:最近修订的国家和地区烟草控制法律。
IF 1.5 3区 哲学 Q2 ETHICS Pub Date : 2025-12-01 Epub Date: 2025-12-22 DOI: 10.1007/s11673-025-10534-4
Michaela Okninski, Cheneal Puljević, Coral Gartner
{"title":"Targeting Illicit Tobacco Trade in Australia: Recent Amendments to State and Territory Tobacco Control Laws.","authors":"Michaela Okninski, Cheneal Puljević, Coral Gartner","doi":"10.1007/s11673-025-10534-4","DOIUrl":"10.1007/s11673-025-10534-4","url":null,"abstract":"","PeriodicalId":50252,"journal":{"name":"Journal of Bioethical Inquiry","volume":" ","pages":"775-780"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient and Public Involvement with Forced Migrants: An Empirical Exploration of Ethical Issues. 耐心和公众参与强迫移民:伦理问题的实证探索。
IF 1.5 3区 哲学 Q2 ETHICS Pub Date : 2025-12-01 Epub Date: 2025-08-12 DOI: 10.1007/s11673-025-10438-3
Elin Inge, Nimo Elmi, Yasmin Omar, Georgina Warner, Ulrik Kihlbom

Patient and public involvement (PPI) with forced migrants can have positive impacts on health research, but empirical knowledge on the ethics of involving forced migrants is scarce. Unsolved ethical issues risk hindering meaningful involvement and jeopardize the research process, as well as harming the public contributors and causing moral distress. In this article, we aimed to identify ethical issues in PPI with forced migrants and present case examples, based on qualitative data and using thematic analysis, as well as analyse the issues using the ethical principles by Beauchamp and Childress as well as PPI-centred values. The ethical issues identified were "Treating forced migrant public contributors as a vulnerable group can inhibit autonomy"; "Non-inclusive communication strategies can contribute to injustice"; "Regulations around payment risk excluding the most vulnerable from involvement"; "Public contributors risk being excluded from partaking in decision-making," and "If trust is not established, public contributors do not feel safe sharing honest input." Further, we discussed the ethical issues using relational ethics, with a focus on how to conduct PPI with forced migrants in an ethical way.

患者和公众参与强迫移徙者可以对卫生研究产生积极影响,但关于强迫移徙者参与的伦理问题的经验知识很少。未解决的伦理问题有可能阻碍有意义的参与,危及研究进程,损害公共贡献者并造成道德困境。在这篇文章中,我们旨在通过定性数据和专题分析来确定强迫移民的PPI中的伦理问题,并利用比彻姆和柴尔德里斯的伦理原则以及以PPI为中心的价值观来分析这些问题。确定的伦理问题是“将被迫移徙的公共捐助者视为弱势群体可能会抑制自治”;“不包容的沟通策略可能导致不公正”;“围绕支付风险的监管将最弱势群体排除在外”;“公共贡献者有被排除在决策之外的风险”,“如果没有建立信任,公共贡献者在分享诚实的意见时就会感到不安全。”此外,我们使用关系伦理讨论了伦理问题,重点是如何以道德的方式对强迫移民进行PPI。
{"title":"Patient and Public Involvement with Forced Migrants: An Empirical Exploration of Ethical Issues.","authors":"Elin Inge, Nimo Elmi, Yasmin Omar, Georgina Warner, Ulrik Kihlbom","doi":"10.1007/s11673-025-10438-3","DOIUrl":"10.1007/s11673-025-10438-3","url":null,"abstract":"<p><p>Patient and public involvement (PPI) with forced migrants can have positive impacts on health research, but empirical knowledge on the ethics of involving forced migrants is scarce. Unsolved ethical issues risk hindering meaningful involvement and jeopardize the research process, as well as harming the public contributors and causing moral distress. In this article, we aimed to identify ethical issues in PPI with forced migrants and present case examples, based on qualitative data and using thematic analysis, as well as analyse the issues using the ethical principles by Beauchamp and Childress as well as PPI-centred values. The ethical issues identified were \"Treating forced migrant public contributors as a vulnerable group can inhibit autonomy\"; \"Non-inclusive communication strategies can contribute to injustice\"; \"Regulations around payment risk excluding the most vulnerable from involvement\"; \"Public contributors risk being excluded from partaking in decision-making,\" and \"If trust is not established, public contributors do not feel safe sharing honest input.\" Further, we discussed the ethical issues using relational ethics, with a focus on how to conduct PPI with forced migrants in an ethical way.</p>","PeriodicalId":50252,"journal":{"name":"Journal of Bioethical Inquiry","volume":" ","pages":"917-930"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12783280/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethical Governance Strategies for the Responsible Innovation of Neurotechnologies: A Scoping Review. 神经技术负责任创新的伦理治理策略:范围审查。
IF 1.5 3区 哲学 Q2 ETHICS Pub Date : 2025-12-01 Epub Date: 2025-11-11 DOI: 10.1007/s11673-025-10440-9
Liam J Robertson, Nathan L Higgins, Moritz J Maier, Adrian Carter, John G Gardner

Following the recent surge in neurotechnology innovation and commercial investment, numerous academic bodies, government bodies, multilateral organizations, and industry leaders have produced ethical guidelines to govern neurotechnology innovation. Many highlight the need for new regulations to protect the rights and welfare of vulnerable individuals, while others warn about unnecessarily impeding innovation that provides urgent treatments to intractable conditions. Consensus on appropriate governance of neurotechnological innovation remains elusive. To fill this gap, we conducted a scoping review of the academic literature concerning the governance of neurotechnology development, identifying the ethical issues addressed, highlighting gaps or underdeveloped areas of neurotechnology governance, and the country in which they were developed. Fifty-one academic articles from the peer-reviewed literature were extracted, selecting those that referred to neurotechnologies and presented normative ethical guidelines or frameworks for their governance. We identified six common ethical themes (justice, beneficence and nonmaleficence, privacy and brain data, autonomy and informed consent, and, identity, dignity, and moral status) and six governance strategies proposed to address these themes (social responsibility and accountability, interdisciplinary collaboration, public engagement, scientific integrity, epistemic humility, legislation and neurorights). Discussions surrounding these themes lacked adequate consideration of diverse viewpoints, such as from the Global South, and were often underdeveloped, lacking both practical specificity and guidance to help developers balance competing priorities. Specifically, animal ethics and binding governance approaches were not adequately addressed, while neurorights were given undue consideration. Future guidelines should engage with these areas to aid in the development of more comprehensive and specific governance documents.

随着最近神经技术创新和商业投资的激增,许多学术机构、政府机构、多边组织和行业领导者都制定了管理神经技术创新的道德准则。许多人强调需要制定新的法规来保护弱势群体的权利和福利,而另一些人则警告说,这会不必要地阻碍为棘手疾病提供紧急治疗的创新。关于神经技术创新的适当治理的共识仍然难以捉摸。为了填补这一空白,我们对有关神经技术发展治理的学术文献进行了范围审查,确定了所解决的伦理问题,突出了神经技术治理的差距或欠发达地区,以及它们发展的国家。从同行评议的文献中提取了51篇学术文章,选择了那些涉及神经技术并提出规范道德准则或治理框架的文章。我们确定了六个共同的伦理主题(正义、慈善和无害、隐私和大脑数据、自主和知情同意,以及身份、尊严和道德地位),并提出了六个治理策略来解决这些主题(社会责任和问责制、跨学科合作、公众参与、科学诚信、认知谦卑、立法和神经权利)。围绕这些主题的讨论缺乏对不同观点的充分考虑,例如来自全球南方的观点,并且往往是不发达的,缺乏实际的特异性和指导来帮助开发人员平衡竞争的优先级。具体来说,动物伦理和有约束力的治理方法没有得到充分解决,而神经权利得到了不适当的考虑。未来的指导方针应该涉及这些领域,以帮助开发更全面和具体的治理文档。
{"title":"Ethical Governance Strategies for the Responsible Innovation of Neurotechnologies: A Scoping Review.","authors":"Liam J Robertson, Nathan L Higgins, Moritz J Maier, Adrian Carter, John G Gardner","doi":"10.1007/s11673-025-10440-9","DOIUrl":"10.1007/s11673-025-10440-9","url":null,"abstract":"<p><p>Following the recent surge in neurotechnology innovation and commercial investment, numerous academic bodies, government bodies, multilateral organizations, and industry leaders have produced ethical guidelines to govern neurotechnology innovation. Many highlight the need for new regulations to protect the rights and welfare of vulnerable individuals, while others warn about unnecessarily impeding innovation that provides urgent treatments to intractable conditions. Consensus on appropriate governance of neurotechnological innovation remains elusive. To fill this gap, we conducted a scoping review of the academic literature concerning the governance of neurotechnology development, identifying the ethical issues addressed, highlighting gaps or underdeveloped areas of neurotechnology governance, and the country in which they were developed. Fifty-one academic articles from the peer-reviewed literature were extracted, selecting those that referred to neurotechnologies and presented normative ethical guidelines or frameworks for their governance. We identified six common ethical themes (justice, beneficence and nonmaleficence, privacy and brain data, autonomy and informed consent, and, identity, dignity, and moral status) and six governance strategies proposed to address these themes (social responsibility and accountability, interdisciplinary collaboration, public engagement, scientific integrity, epistemic humility, legislation and neurorights). Discussions surrounding these themes lacked adequate consideration of diverse viewpoints, such as from the Global South, and were often underdeveloped, lacking both practical specificity and guidance to help developers balance competing priorities. Specifically, animal ethics and binding governance approaches were not adequately addressed, while neurorights were given undue consideration. Future guidelines should engage with these areas to aid in the development of more comprehensive and specific governance documents.</p>","PeriodicalId":50252,"journal":{"name":"Journal of Bioethical Inquiry","volume":" ","pages":"931-948"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12783205/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145490870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preparing Adolescents and Equipping Parents for End-of-Life Care Preventing and Mitigating Moral Dilemmas. 准备青少年和装备父母临终关怀预防和减轻道德困境。
IF 1.5 3区 哲学 Q2 ETHICS Pub Date : 2025-12-01 Epub Date: 2025-11-10 DOI: 10.1007/s11673-025-10505-9
Meaghann S Weaver, Erica Kaye, Liza M Johnson, Marta Salek, Lori Wiener
{"title":"Preparing Adolescents and Equipping Parents for End-of-Life Care Preventing and Mitigating Moral Dilemmas.","authors":"Meaghann S Weaver, Erica Kaye, Liza M Johnson, Marta Salek, Lori Wiener","doi":"10.1007/s11673-025-10505-9","DOIUrl":"10.1007/s11673-025-10505-9","url":null,"abstract":"","PeriodicalId":50252,"journal":{"name":"Journal of Bioethical Inquiry","volume":" ","pages":"1005-1007"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145483478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Even Fairer Exchange: Further Reasons Why Living Kidney Donors in England Should Be Financially Compensated. 更公平的交换:英国活体肾脏捐赠者应该得到经济补偿的进一步原因。
IF 1.5 3区 哲学 Q2 ETHICS Pub Date : 2025-12-01 Epub Date: 2025-06-03 DOI: 10.1007/s11673-024-10420-5
Richard C Armitage

Rodger and Venter have proposed a monopsony system in which the National Health Service (NHS) in England, as the single buyer, allows living kidney donors to opt-in to receive £35,000 tax-free financial compensation while preserving the right to donate without such compensation. This approach aims to alleviate the severe and growing shortage of kidneys available for transplant in England and is projected to generate substantial economic savings for the NHS. This paper sets out to strengthen their proposal by: (1) presenting updated figures on the increasing kidney transplant wait list in England to highlight the urgency for intervention; (2) detailing the rigor of the existing donor evaluation process to mitigate concerns about exploitation and coercion in compensated living donation; (3) outlining the various kinds of living kidney donation and the U.K. Living Kidney Sharing Scheme, to demonstrate that the proposal's projected economic benefits are likely to be underestimations; (4) suggesting five modifications to the proposal that do not significantly alter its underlying structure; and (5) providing additional arguments against the major objections to such proposals-that financial compensation is exploitative, coercive, and likely to "crowd out" altruistic donors-and showing how the five suggested modifications could strengthen the proposal by bolstering it against those objections. The paper strengthens existing arguments for a pilot project of financial compensation for living kidney donors in England.

罗杰和文特尔提出了一种垄断制度,在这种制度下,英国国家医疗服务体系(NHS)作为唯一的买家,允许活体肾脏捐赠者选择接受3.5万英镑的免税经济补偿,同时保留没有这种补偿的捐赠权利。这种方法旨在缓解英国严重且日益严重的可移植肾脏短缺问题,并预计将为NHS节省大量经济开支。本文旨在通过以下方式加强他们的建议:(1)介绍英国不断增加的肾脏移植等待名单的最新数据,以强调干预的紧迫性;(2)详细说明现有捐赠者评估过程的严谨性,以减轻对有偿活体捐赠中剥削和胁迫的担忧;(3)概述各种活体肾脏捐赠和英国活体肾脏共享计划,以证明该建议的预期经济效益可能被低估;(四)对提案提出五项修改意见,对提案的基本结构没有重大改变;(5)针对这些提案的主要反对意见——经济补偿是剥削性的、强制性的,可能会“排挤”无私的捐助者——提供了额外的论据,并展示了五种建议的修改如何通过支持这些反对意见来加强提案。这篇论文加强了对英国活体肾捐赠者经济补偿试点项目的现有争论。
{"title":"An Even Fairer Exchange: Further Reasons Why Living Kidney Donors in England Should Be Financially Compensated.","authors":"Richard C Armitage","doi":"10.1007/s11673-024-10420-5","DOIUrl":"10.1007/s11673-024-10420-5","url":null,"abstract":"<p><p>Rodger and Venter have proposed a monopsony system in which the National Health Service (NHS) in England, as the single buyer, allows living kidney donors to opt-in to receive £35,000 tax-free financial compensation while preserving the right to donate without such compensation. This approach aims to alleviate the severe and growing shortage of kidneys available for transplant in England and is projected to generate substantial economic savings for the NHS. This paper sets out to strengthen their proposal by: (1) presenting updated figures on the increasing kidney transplant wait list in England to highlight the urgency for intervention; (2) detailing the rigor of the existing donor evaluation process to mitigate concerns about exploitation and coercion in compensated living donation; (3) outlining the various kinds of living kidney donation and the U.K. Living Kidney Sharing Scheme, to demonstrate that the proposal's projected economic benefits are likely to be underestimations; (4) suggesting five modifications to the proposal that do not significantly alter its underlying structure; and (5) providing additional arguments against the major objections to such proposals-that financial compensation is exploitative, coercive, and likely to \"crowd out\" altruistic donors-and showing how the five suggested modifications could strengthen the proposal by bolstering it against those objections. The paper strengthens existing arguments for a pilot project of financial compensation for living kidney donors in England.</p>","PeriodicalId":50252,"journal":{"name":"Journal of Bioethical Inquiry","volume":" ","pages":"791-800"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12783283/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144210096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Balancing Parental and Child Interests in Research Subject Compensation. 研究对象补偿中父母与子女利益的平衡。
IF 1.5 3区 哲学 Q2 ETHICS Pub Date : 2025-12-01 Epub Date: 2025-06-17 DOI: 10.1007/s11673-025-10436-5
J M Appel

Both minors enrolled in human subject research and their parents often receive compensation for the former's participation. While considerable literature addresses the ethics of such compensation, the existing literature does not yet consider the challenge of minors and parents who may have divergent views regarding how such compensation should be expended. Since parents generally have broad legal authority over both monetary and in-kind compensation received by their children, ensuring that compensation earmarked for minor subjects are actually expended in accordance with the subjects' interests may prove challenging. This paper assesses the existing legal and ethical landscape in this area and proposes several potential mechanisms through which researchers and IRBs might address this largely overlooked dilemma.

参加人体研究的未成年人和他们的父母经常会因为前者的参与而获得补偿。虽然相当多的文献讨论了这种补偿的伦理问题,但现有的文献还没有考虑到未成年人和父母的挑战,他们可能对如何使用这种补偿有不同的看法。由于父母通常对子女获得的货币和实物补偿拥有广泛的法律权力,因此,确保指定给未成年人的补偿实际上是根据未成年人的利益支出的,这可能是一项挑战。本文评估了这一领域现有的法律和伦理景观,并提出了一些潜在的机制,通过这些机制,研究人员和内部审查委员会可能会解决这一很大程度上被忽视的困境。
{"title":"Balancing Parental and Child Interests in Research Subject Compensation.","authors":"J M Appel","doi":"10.1007/s11673-025-10436-5","DOIUrl":"10.1007/s11673-025-10436-5","url":null,"abstract":"<p><p>Both minors enrolled in human subject research and their parents often receive compensation for the former's participation. While considerable literature addresses the ethics of such compensation, the existing literature does not yet consider the challenge of minors and parents who may have divergent views regarding how such compensation should be expended. Since parents generally have broad legal authority over both monetary and in-kind compensation received by their children, ensuring that compensation earmarked for minor subjects are actually expended in accordance with the subjects' interests may prove challenging. This paper assesses the existing legal and ethical landscape in this area and proposes several potential mechanisms through which researchers and IRBs might address this largely overlooked dilemma.</p>","PeriodicalId":50252,"journal":{"name":"Journal of Bioethical Inquiry","volume":" ","pages":"801-809"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144318556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-Effectiveness and the Distinction Between Quantitative and Qualitative Disability Discrimination. 成本效益与定量和定性残疾歧视的区别。
IF 1.5 3区 哲学 Q2 ETHICS Pub Date : 2025-12-01 Epub Date: 2025-07-22 DOI: 10.1007/s11673-025-10431-w
Lasse Nielsen

Since standard measures of health effect ascribe negative value to disabilities, it is commonly believed that a cost-effective scheme for allocation of healthcare resources discriminates against people with disabilities. It is still a question for discussion, however, when and why such discrimination is justified. In this paper I account for the central normative substance of this disability discrimination problem, and I defend the claim that it is more justifiable to discriminate against disabled people based on lifespan considerations than on assessments of their reduced quality of life. I term this the asymmetry intuition. Based on some prior attempts to explain the asymmetry intuition, I offer the Reasonable Impartial Interest Argument as the best possible way to defend it. If my argument is sound, this moves us a step further towards a cost-effective priority setting that does not unjustly discriminate against people with disabilities.

由于健康影响的标准措施将负面价值归因于残疾,因此人们普遍认为,具有成本效益的医疗资源分配方案是对残疾人的歧视。然而,何时以及为什么这种歧视是合理的,这仍然是一个有待讨论的问题。在本文中,我解释了残疾歧视问题的核心规范内容,并为以下观点辩护:基于寿命的考虑而不是基于生活质量下降的评估来歧视残疾人更有道理。我称之为不对称直觉。基于之前一些解释不对称直觉的尝试,我提出了合理的公正利益论证,作为捍卫它的最佳方式。如果我的论点是正确的,这将使我们朝着成本效益高、不会不公平地歧视残疾人的优先事项设定迈进一步。
{"title":"Cost-Effectiveness and the Distinction Between Quantitative and Qualitative Disability Discrimination.","authors":"Lasse Nielsen","doi":"10.1007/s11673-025-10431-w","DOIUrl":"10.1007/s11673-025-10431-w","url":null,"abstract":"<p><p>Since standard measures of health effect ascribe negative value to disabilities, it is commonly believed that a cost-effective scheme for allocation of healthcare resources discriminates against people with disabilities. It is still a question for discussion, however, when and why such discrimination is justified. In this paper I account for the central normative substance of this disability discrimination problem, and I defend the claim that it is more justifiable to discriminate against disabled people based on lifespan considerations than on assessments of their reduced quality of life. I term this the asymmetry intuition. Based on some prior attempts to explain the asymmetry intuition, I offer the Reasonable Impartial Interest Argument as the best possible way to defend it. If my argument is sound, this moves us a step further towards a cost-effective priority setting that does not unjustly discriminate against people with disabilities.</p>","PeriodicalId":50252,"journal":{"name":"Journal of Bioethical Inquiry","volume":" ","pages":"851-862"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12783164/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144692269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Traditional Healthcare Practitioners' Views on Informed Consent in African Traditional Medicine: A Qualitative Study in KwaZulu-Natal, South Africa. 传统医疗从业者对非洲传统医学知情同意的看法:南非夸祖鲁-纳塔尔省的一项定性研究。
IF 1.5 3区 哲学 Q2 ETHICS Pub Date : 2025-12-01 Epub Date: 2025-11-11 DOI: 10.1007/s11673-025-10433-8
F F Akpa-Inyang

African traditional medicine provides treatment for various illnesses and is widely used across Africa since it is readily available and affordable. Concepts of informed consent, however, are grounded in a Western ethical tradition that foregrounds the individual's rights to autonomy and bodily integrity. This study aimed to explore whether the basic elements of informed consent-information disclosure, comprehension, voluntariness, and agreement-are observed in traditional medicine practice in KwaZulu-Natal province, South Africa. Semi-structured in-depth interviews were conducted with eight traditional healers-four nyanga and four sangoma, and thematic content analysis was applied to the transcribed and translated data. Four major themes emerged from this analysis: 1) the practice of traditional medicine in KwaZulu-Natal; 2) the importance and amount of information disclosure by traditional healers; 3) methods used to obtain consent or agreement from patients and the voluntariness of this process; 4) the benefits of and barriers to obtaining informed consent in African traditional medicine. The study found that African traditional healers do indeed disclose information on diagnosis, risks, benefits, and treatment options to their patients.

非洲传统医学可以治疗各种疾病,由于容易获得和负担得起,因此在非洲广泛使用。然而,知情同意的概念是建立在西方伦理传统的基础上的,这种传统强调个人的自主权和身体完整性。本研究旨在探讨知情同意的基本要素——信息披露、理解、自愿和同意——在南非夸祖鲁-纳塔尔省的传统医学实践中是否得到遵守。对8位传统治疗师(4位尼扬加和4位桑戈马)进行了半结构化的深度访谈,并对转录和翻译的数据进行了主题内容分析。从这一分析中出现了四个主要主题:1)夸祖鲁-纳塔尔省的传统医学实践;2)传统治疗师披露信息的重要性和数量;3)获得患者同意或同意的方法以及该过程的自愿性;4)在非洲传统医学中获得知情同意的好处和障碍。研究发现,非洲传统治疗师确实会向患者透露有关诊断、风险、益处和治疗方案的信息。
{"title":"Traditional Healthcare Practitioners' Views on Informed Consent in African Traditional Medicine: A Qualitative Study in KwaZulu-Natal, South Africa.","authors":"F F Akpa-Inyang","doi":"10.1007/s11673-025-10433-8","DOIUrl":"10.1007/s11673-025-10433-8","url":null,"abstract":"<p><p>African traditional medicine provides treatment for various illnesses and is widely used across Africa since it is readily available and affordable. Concepts of informed consent, however, are grounded in a Western ethical tradition that foregrounds the individual's rights to autonomy and bodily integrity. This study aimed to explore whether the basic elements of informed consent-information disclosure, comprehension, voluntariness, and agreement-are observed in traditional medicine practice in KwaZulu-Natal province, South Africa. Semi-structured in-depth interviews were conducted with eight traditional healers-four nyanga and four sangoma, and thematic content analysis was applied to the transcribed and translated data. Four major themes emerged from this analysis: 1) the practice of traditional medicine in KwaZulu-Natal; 2) the importance and amount of information disclosure by traditional healers; 3) methods used to obtain consent or agreement from patients and the voluntariness of this process; 4) the benefits of and barriers to obtaining informed consent in African traditional medicine. The study found that African traditional healers do indeed disclose information on diagnosis, risks, benefits, and treatment options to their patients.</p>","PeriodicalId":50252,"journal":{"name":"Journal of Bioethical Inquiry","volume":" ","pages":"881-898"},"PeriodicalIF":1.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145490912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rethinking Patient Consent in AI-Enhanced Healthcare: A Teleological and Consequential Ethical Framework. 重新思考人工智能增强医疗保健中的患者同意:目的论和后果伦理框架。
IF 1.5 3区 哲学 Q2 ETHICS Pub Date : 2025-11-26 DOI: 10.1007/s11673-025-10535-3
Mohammad Mohi Uddin
{"title":"Rethinking Patient Consent in AI-Enhanced Healthcare: A Teleological and Consequential Ethical Framework.","authors":"Mohammad Mohi Uddin","doi":"10.1007/s11673-025-10535-3","DOIUrl":"https://doi.org/10.1007/s11673-025-10535-3","url":null,"abstract":"","PeriodicalId":50252,"journal":{"name":"Journal of Bioethical Inquiry","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145606999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Bioethical Inquiry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1